Clinical Trials List
Protocol NumberTAI-301
Active
2021-10-01 - 2025-12-31
Phase I
Recruiting3
-
Trial Applicant
Efficient Pharma Management Corp.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Ching Wang Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- San-Chi Chen Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Yee Chao Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
